University of Aberdeen-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Aberdeen - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013359
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Aberdeen (UOA) is an educational and research institution that offers undergraduate, graduate, postgraduate and research programs in a range of subjects. The university offers undergraduate and postgraduate courses in the areas of arts, creative arts, commerce, education, engineering, health and behavioral sciences, informatics, law and science. It offers research courses across various fields such as arts and social sciences, life sciences and medicine and physical sciences. The university also provide supports and promotes research excellence in all its many forms, stimulating, supportive and inspiring environment working alongside world-leading research, consultancy services across all subjects and disciplines including materials analysis and testing; oil and gas related topics; industrial psychology; deep-sea monitoring and environmental and occupational medicine. UOA is headquartered in Aberdeen, the UK.

University of Aberdeen – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Aberdeen, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Aberdeen, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Aberdeen, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Aberdeen, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Aberdeen, Medical Devices Deals, 2011 to YTD 2017 9
University of Aberdeen, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Aberdeen, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cell Therapy Catapult Forms Joint Venture with University of Aberdeen 11
MRC Technology Enters Into Co-Development Agreement With University Of Aberdeen 12
TPP Global Development Enters Into Agreement With University of Aberdeen 13
Equity Offering 14
Elasmogen Spin Off from University of Aberdeen 14
University of Aberdeen – Key Competitors 15
University of Aberdeen – Key Employees 16
University of Aberdeen – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 18
Strategy And Business Planning 18
May 18, 2016: New company created to develop novel technology to treat diabetes 18
Product News 20
May 11, 2016: New UK-wide clinical trial aims to improve muscle strength in older people 20
Mar 03, 2017: Trial finds huge success in HIV treatment 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
University of Aberdeen, Pharmaceuticals & Healthcare, Key Facts 2
University of Aberdeen, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Aberdeen, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Aberdeen, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Aberdeen, Deals By Therapy Area, 2011 to YTD 2017 8
University of Aberdeen, Medical Devices Deals, 2011 to YTD 2017 9
University of Aberdeen, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cell Therapy Catapult Forms Joint Venture with University of Aberdeen 11
MRC Technology Enters Into Co-Development Agreement With University Of Aberdeen 12
TPP Global Development Enters Into Agreement With University of Aberdeen 13
Elasmogen Spin Off from University of Aberdeen 14
University of Aberdeen, Key Competitors 15
University of Aberdeen, Key Employees 16
University of Aberdeen, Joint Venture 17

★海外企業調査レポート[University of Aberdeen-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Altana Ag:企業の戦略・SWOT・財務分析
    Altana Ag - Strategy, SWOT and Corporate Finance Report Summary Altana Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Achillion Pharmaceuticals Inc (ACHN):製薬・医療:M&Aディール及び事業提携情報
    Summary Achillion Pharmaceuticals Inc (Achillion) is a biopharmaceutical company which focuses on the discovery and development of small molecule therapeutic products for treatment of infectious diseases and immune system disorders. The company focuses at developing life-saving medicines to patients …
  • Ossur hf (OSSR):医療機器:M&Aディール及び事業提携情報
    Summary Ossur hf. (Ossur) is an orthopedic devices company. It develops, manufactures and sells prosthetics, and bracing and support products. The company’s key areas of expertise include silicone, carbon composites, mechatronics and textiles. Ossur offers ankle and foot supports, knee braces, neck …
  • Cognizant Technology Solutions Corporation:戦略・SWOT・企業財務分析
    Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Sime Darby Berhad:企業の戦略・SWOT・財務情報
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mosman Oil & Gas Ltd (MSMN):石油・ガス:M&Aディール及び事業提携情報
    Summary Mosman Oil & Gas Ltd (MOG) is an oil and gas company. The company operates in the exploration, development, and production of oil and gas projects. Its projects include amadeus basin, welch permian basin, blackstone strategic alliance, strawn oil project, and arkoma stacked pay project. MOG’ …
  • Badger Mutual Insurance Co:企業の戦略的SWOT分析
    Badger Mutual Insurance Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • CSA Medical Inc-医療機器分野:企業M&A・提携分析
    Summary CSA Medical Inc (CSA Medical) is a medical device company that offers cryotherapy devices. The company provides spray cryotherapy medical device solutions to improve patient outcomes, simplify procedures, and reduce the cost of healthcare. Its truFreeze system delivers cold liquid nitrogen s …
  • PBF Energy Inc (PBF):石油・ガス:M&Aディール及び事業提携情報
    Summary PBF Energy Inc. (PBF Energy) is an independent oil refining company. It owns and operates crude oil refineries and related facilities in the US. Its refining assets include Delaware City refinery, Delaware; Paulsboro refinery, New Jersey; Chalmette refinery, Louisiana, Torrance, California a …
  • Elos Medtech AB (ELOS B):企業の財務・戦略的SWOT分析
    Elos Medtech AB (ELOS B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kwality Group
    Kwality Group - Strategy, SWOT and Corporate Finance Report Summary Kwality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Renk AG (ZAR):企業の財務・戦略的SWOT分析
    Renk AG (ZAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Menlo Therapeutics Inc (MNLO):製薬・医療:M&Aディール及び事業提携情報
    Summary Menlo Therapeutics Inc (Menlo Therapeutics) formerly Tigercat Pharma Inc, is a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions such as psoriasis and prurigo nodularis, a …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Crexendo Inc (CXDO):企業の財務・戦略的SWOT分析
    Summary Crexendo Inc (Crexendo) is a technology company that offers critical voice and data technology infrastructure services. The company offers internet phones, colour internet phones, SIP phone, DTA phones and mobile applications. It offers cloud communication and network services. Crexendo’s ne …
  • Abbott Molecular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Molecular Inc (Abbott Molecular), formerly Vysis Inc, a subsidiary of Abbott Laboratories, is a medical diagnostics company that provides molecular testing solutions. The company offers infectious disease products, oncology products, genetics products, automation products, molecular d …
  • Shionogi Inc:企業の戦略的SWOT分析
    Shionogi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Perpetual Limited (PPT):企業の財務・戦略的SWOT分析
    Perpetual Limited (PPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Universal Health Services Inc (UHS):企業の財務・戦略的SWOT分析
    Universal Health Services Inc (UHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆